Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Price:
1 795.3
INR
0.86%
Market Closed
Market Cap:
4.3T
INR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
SUNPHARMA Alert
Sun Pharmaceutical Industries Ltd
1795.3
+15.3 (+0.86%)
| 52 Week Range |
1 191.35
1 948.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Sun Pharmaceutical Industries Ltd
Balance Sheet
Balance Sheet Decomposition
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
| Current Assets | 460.7B |
| Cash & Short-Term Investments | 207.6B |
| Receivables | 129.9B |
| Other Current Assets | 123.2B |
| Non-Current Assets | 420.5B |
| Long-Term Investments | 68.1B |
| PP&E | 112.5B |
| Intangibles | 182.2B |
| Other Non-Current Assets | 57.7B |
| Current Liabilities | 172.5B |
| Accounts Payable | 57.3B |
| Other Current Liabilities | 115.2B |
| Non-Current Liabilities | 17.5B |
| Long-Term Debt | 3.7B |
| Other Non-Current Liabilities | 13.8B |
Balance Sheet
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Currency: INR
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
94 612
|
104 701
|
115 556
|
74 437
|
35 973
|
27 011
|
64 331
|
50 209
|
57 574
|
105 055
|
|
| Cash |
36 862
|
50 808
|
64 504
|
19 283
|
1 659
|
7 908
|
30 004
|
26 769
|
43 702
|
12 199
|
|
| Cash Equivalents |
57 750
|
53 893
|
51 052
|
55 154
|
34 314
|
19 103
|
34 328
|
23 439
|
13 872
|
92 857
|
|
| Short-Term Investments |
36 655
|
34 094
|
37 955
|
65 333
|
75 854
|
86 654
|
31 302
|
76 961
|
93 903
|
86 080
|
|
| Total Receivables |
63 000
|
80 541
|
84 761
|
82 191
|
95 553
|
99 408
|
93 248
|
121 851
|
129 598
|
132 557
|
|
| Accounts Receivables |
50 928
|
67 605
|
71 811
|
78 153
|
88 842
|
94 212
|
91 042
|
105 139
|
114 893
|
113 030
|
|
| Other Receivables |
12 072
|
12 936
|
12 950
|
4 038
|
6 711
|
5 196
|
2 205
|
16 712
|
14 705
|
19 527
|
|
| Inventory |
56 669
|
64 225
|
68 328
|
68 807
|
78 860
|
78 750
|
93 618
|
92 392
|
109 683
|
102 949
|
|
| Other Current Assets |
37 847
|
15 852
|
22 937
|
25 591
|
24 452
|
24 718
|
21 923
|
7 234
|
7 861
|
7 690
|
|
| Total Current Assets |
288 782
|
299 413
|
329 537
|
316 359
|
310 692
|
316 542
|
304 421
|
348 646
|
398 619
|
434 331
|
|
| PP&E Net |
85 318
|
87 866
|
100 601
|
105 935
|
109 382
|
112 263
|
111 715
|
111 689
|
113 537
|
113 001
|
|
| PP&E Gross |
85 318
|
87 866
|
100 601
|
105 935
|
109 382
|
112 263
|
111 715
|
111 689
|
113 537
|
113 001
|
|
| Accumulated Depreciation |
33 617
|
47 201
|
49 041
|
57 174
|
67 281
|
79 168
|
90 387
|
100 376
|
116 226
|
125 760
|
|
| Intangible Assets |
11 530
|
36 264
|
48 803
|
51 176
|
63 537
|
63 595
|
56 607
|
61 918
|
93 268
|
86 663
|
|
| Goodwill |
54 846
|
56 347
|
55 362
|
56 067
|
59 558
|
64 815
|
62 876
|
65 913
|
87 127
|
85 990
|
|
| Note Receivable |
13 069
|
16 799
|
31 948
|
59 715
|
37 365
|
39 385
|
38 218
|
26 225
|
24 488
|
24 855
|
|
| Long-Term Investments |
14 459
|
20 580
|
15 533
|
30 606
|
39 640
|
52 458
|
64 827
|
52 152
|
54 575
|
64 412
|
|
| Other Long-Term Assets |
33 596
|
38 034
|
32 319
|
25 305
|
26 764
|
33 467
|
38 004
|
31 536
|
35 821
|
45 378
|
|
| Other Assets |
54 846
|
56 347
|
55 362
|
56 067
|
59 558
|
64 815
|
62 876
|
65 913
|
87 127
|
85 990
|
|
| Total Assets |
501 601
N/A
|
555 303
+11%
|
614 102
+11%
|
645 164
+5%
|
646 938
+0%
|
682 525
+6%
|
676 667
-1%
|
698 078
+3%
|
807 436
+16%
|
854 629
+6%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
32 430
|
35 829
|
43 954
|
47 662
|
41 479
|
40 937
|
39 737
|
44 898
|
56 815
|
56 533
|
|
| Accrued Liabilities |
320
|
439
|
384
|
336
|
382
|
94
|
7 383
|
14 833
|
15 127
|
16 889
|
|
| Short-Term Debt |
62 127
|
52 061
|
66 549
|
79 797
|
83 708
|
55 494
|
24 449
|
4 685
|
59 583
|
28 444
|
|
| Current Portion of Long-Term Debt |
13 998
|
1 803
|
17 408
|
6 335
|
6 210
|
7 366
|
5 256
|
3 401
|
3 677
|
1 257
|
|
| Other Current Liabilities |
44 419
|
41 307
|
50 575
|
64 514
|
41 619
|
53 174
|
84 632
|
104 268
|
63 862
|
66 715
|
|
| Total Current Liabilities |
153 294
|
131 440
|
178 870
|
198 643
|
173 396
|
157 064
|
161 456
|
172 085
|
199 064
|
169 838
|
|
| Long-Term Debt |
13 598
|
31 103
|
14 361
|
17 721
|
15 226
|
20 289
|
8 981
|
4 817
|
5 599
|
3 036
|
|
| Deferred Income Tax |
751
|
1 194
|
3 286
|
2 190
|
1 043
|
581
|
445
|
319
|
317
|
1 551
|
|
| Minority Interest |
28 512
|
40 853
|
37 909
|
38 842
|
33 135
|
38 602
|
30 171
|
30 549
|
33 201
|
34 392
|
|
| Other Liabilities |
25 031
|
20 889
|
13 280
|
4 627
|
10 047
|
13 343
|
10 986
|
10 196
|
9 301
|
9 145
|
|
| Total Liabilities |
221 186
N/A
|
225 478
+2%
|
247 706
+10%
|
262 022
+6%
|
232 848
-11%
|
229 880
-1%
|
212 040
-8%
|
217 966
+3%
|
247 482
+14%
|
217 961
-12%
|
|
| Equity | |||||||||||
| Common Stock |
2 071
|
2 407
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
|
| Retained Earnings |
252 716
|
288 801
|
344 705
|
357 167
|
372 863
|
392 785
|
405 620
|
416 096
|
475 742
|
541 185
|
|
| Additional Paid In Capital |
18 369
|
18 592
|
11 895
|
11 929
|
11 933
|
11 874
|
11 874
|
11 874
|
11 874
|
11 874
|
|
| Unrealized Security Profit/Loss |
6 923
|
4 082
|
336
|
1 555
|
1 622
|
216
|
4 286
|
1 623
|
2 150
|
10 245
|
|
| Other Equity |
335
|
15 943
|
7 062
|
10 091
|
25 273
|
45 370
|
40 448
|
48 120
|
67 789
|
70 964
|
|
| Total Equity |
280 415
N/A
|
329 825
+18%
|
366 397
+11%
|
383 141
+5%
|
414 091
+8%
|
452 645
+9%
|
464 628
+3%
|
480 112
+3%
|
559 954
+17%
|
636 668
+14%
|
|
| Total Liabilities & Equity |
501 601
N/A
|
555 303
+11%
|
614 102
+11%
|
645 164
+5%
|
646 938
+0%
|
682 525
+6%
|
676 667
-1%
|
698 078
+3%
|
807 436
+16%
|
854 629
+6%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2 071
|
2 407
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
2 399
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
